Bharat Immunologicals & Biologicals Corporation Ltd Q3 Results
- BSE: 524663
- NSE: -
- ISIN: INE994B01014
- Sector: Biotechnology & Drugs
BSE
16.73
-0.09 (-0.54%)
-0.09 (-0.54%)Volume7.19 K
Updated: Fri 17 Jul, 2026 | 15:55:26
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 22
Note: Comparison is on QoQ basis
Quarterly - Bharat Immunologicals & Biologicals Corporation Ltd Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 22 | Sep 22 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 4.76 | 29.02 | -83.58% |
| Depreciation/ Amortization | 0.04 | 0.04 | 0.00% |
| Operating Income | -4.76 | -2.54 | 87.78% |
| Net Income | -4.68 | -3.08 | 51.90% |
| Net Income Before Taxes | -6.33 | -3.96 | 59.86% |
| Other Operating Expenses Total | 1.95 | 0.65 | 199.74% |
| Total Revenue | 0.00 | 26.48 | 0.00% |
| Diluted Normalized EPS | -1.08 | -0.71 | 52.11% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
- Bharat Immunologicals & Biologicals Corporation Ltd share price
- Bharat Immunologicals & Biologicals Corporation Ltd Profit Loss
- Bharat Immunologicals & Biologicals Corporation Ltd Balance Sheet
- Bharat Immunologicals & Biologicals Corporation Ltd Cashflow
- Bharat Immunologicals & Biologicals Corporation Ltd Q1 Results
- Bharat Immunologicals & Biologicals Corporation Ltd Q2 Results
- Bharat Immunologicals & Biologicals Corporation Ltd Q4 Results
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.